The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas
Abstract
OBJECTIVE: Propranolol hydrochloride is a safe and effective medication for treating infantile hemangiomas (IHs), with decreases in IH volume, color, and elevation. METHODS: Forty children between the ages of 9 weeks and 5 years with facial IHs or IHs in sites with the potential for disfigurement were randomly assigned to receive propranolol or placebo oral solution 2 mg/kg per day divided 3 times daily for 6 months. Baseline electrocardiogram, echocardiogram, and laboratory evaluations were performed. Monitoring of heart rate, blood pressure, and blood glucose was performed at each visit. Children younger than 6 months were admitted to the hospital for monitoring after their first dose at weeks 1 and 2. Efficacy was assessed by performing blinded volume measurements at weeks 0, 4, 8, 12, 16, 20, and 24 and blinded investigator scoring of photographs at weeks 0, 12, and 24. RESULTS: IH growth stopped by week 4 in the propranolol group. Significant differences in the percent change in volume were seen between groups, with the largest difference at week 12. Significant decrease in IH redness and elevation occurred in the propranolol group at weeks 12 and 24 (P = .01 and .001, respectively). No significant hypoglycemia, hypotension, or bradycardia occurred. One child discontinued the study because of an upper respiratory tract infection. Other adverse events included bronchiolitis, gastroenteritis, streptococcal infection, cool extremities, dental caries, and sleep disturbance. CONCLUSION: Propranolol hydrochloride administered orally at 2 mg/kg per day reduced the volume, color, and elevation of focal and segmental IH in infants younger than 6 months and children up to 5 years of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Propranolol for Severe Hemangiomas of Infancy
Léauté-Labrèze, C., de la Roque, E. D., Hubiche, T., Boralevi, F., Thambo, J.-B., & Taïeb, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0708819 · Cited by 2,374
Growth Characteristics of Infantile Hemangiomas: Implications for Management
Chang, L. C., Haggstrom, A. N., Drolet, B. A., Baselga, E., Chamlin, S. L., Garzon, M. C., Horii, K. A., Lucky, A. W., Mancini, A. J., Metry, D. W., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-2767 · Cited by 694
Propranolol for Severe Infantile Hemangiomas: Follow-Up Report
Sans, V., de la Roque, E. D., Berge, J., Grenier, N., Boralevi, F., Mazereeuw-Hautier, J., Lipsker, D., Dupuis, E., Ezzedine, K., Vergnes, P., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-3458 · Cited by 568
Storch, C. H., & Hoeger, P. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09848.x · Cited by 526
Oral Corticosteroid Use Is Effective for Cutaneous Hemangiomas
Bennett, M. L., Fleischer, A. B., Chamlin, S. L., & Frieden, I. J. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.9.1208 · Cited by 345
Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations
Lawley, L. P., Siegfried, E. C., & Todd, J. L. (2009) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2009.00975.x · Cited by 292
Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center
Buckmiller, L. M., Munson, P. D., Dyamenahalli, U., Dai, Y., & Richter, G. T. (2010) · The Laryngoscope · doi:10.1002/lary.20807 · Cited by 203
Propranolol for complicated infantile haemangiomas: a case series of 30 infants: Correspondence
Manunza, F., Syed, S., Laguda, B., Linward, J., Kennedy, H., Gholam, K., Glover, M., Giardini, A., & Harper, J. I. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09597.x · Cited by 187
BETA BLOCKADE INDUCES APOPTOSIS IN CULTURED CAPILLARY ENDOTHELIAL CELLS
Smith, S. K. S., & Smith, D. M. (2002) · In Vitro Cellular & Developmental Biology - Animal · Cited by 177
Efficacy of Propranolol in Hepatic Infantile Hemangiomas with Diffuse Neonatal Hemangiomatosis
Mazereeuw-Hautier, J., Hoeger, P. H., Benlahrech, S., Ammour, A., Broue, P., Vial, J., Ohanessian, G., Léauté-Labrèze, C., Labenne, M., Vabres, P., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.003 · Cited by 162
Cited by
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
Léauté-Labrèze, C., Hoeger, P., Mazereeuw-Hautier, J., Guibaud, L., Baselga, E., Posiunas, G., Phillips, R. J., Caceres, H., Lopez Gutierrez, J. C., Ballona, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404710 · Cited by 801
Self-citationInitiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Drolet, B. A., Frommelt, P. C., Chamlin, S. L., Haggstrom, A., Bauman, N. M., Chiu, Y. E., Chun, R. H., Garzon, M. C., Holland, K. E., Liberman, L., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1691 · Cited by 591
Diagnosis and Management of Infantile Hemangioma
Darrow, D. H., Greene, A. K., Mancini, A. J., Nopper, A. J., the SECTION ON DERMATOLOGY, S. O. O. A. N. S., Antaya, R. J., Cohen, B., Drolet, B. A., Fay, A., Fishman, S. J., et al. (2015) · Pediatrics · doi:10.1542/peds.2015-2485 · Cited by 293
Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants
Mendoza-Cruz, A. C., Wargon, O., Adams, S., Tran, H., & Verge, C. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2649 · Cited by 16
Self-citation
Metadata
- Authors
- Hogeling, M., Adams, S., & Wargon, O.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2011-08-01
- Volume
- 128
- Issue
- 2
- Pages
- e259-e266
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2148017240
- Cited by
- 283
- References
- 16
- FWCI
- 32.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas. https://app.cochat.ai/papers/10.1542/peds.2010-0029
- The paper
- Hogeling, M., Adams, S., & Wargon, O. (2011). A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas. Pediatrics. https://doi.org/10.1542/peds.2010-0029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.